Literature DB >> 10080156

Microsatellite instability is absent in liver and biliary mucosa of patients with primary sclerosing cholangitis.

S Y Jin1, A E Noffsinger, P Bejarano, F L Weber, D W Hanto, J M Belli, C M Fenoglio-Preiser.   

Abstract

Microsatellite instability occurs in the colonic mucosa of patients with inflammatory bowel disease and may predispose the mucosa to neoplastic transformation. It is unknown whether microsatellite instability also plays a role in the neoplastic risk associated with primary sclerosing cholangitis. We examined 134 tissue samples from 21 patients with sclerosing cholangitis for microsatellite instability at eight loci. All tissues were also stained immunohistochemically using an antibody to the proliferation marker Ki-67. Microsatellite instability did not occur in any samples from the intrahepatic or extrahepatic biliary system, although one patient demonstrated instability in the colon. Ki-67 indices ranged from 0 to 2.5 in nondysplastic biliary epithelium and from 1.5 to 29.4 in areas of dysplasia. The absence of microsatellite instability in sclerosing cholangitis suggests that the genetic basis of neoplastic progression in chronic inflammatory disease of the bile ducts differs from that of intestinal cancers arising in the setting of chronic inflammatory bowel disease and may relate to differences in the microenvironment in these two sites.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10080156     DOI: 10.1023/a:1026621827208

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  40 in total

1.  Sclerosing cholangitis in ulcerative colitis. A follow-up study.

Authors:  E Schrumpf; O Fausa; F Kolmannskog; K Elgjo; S Ritland; E Gjone
Journal:  Scand J Gastroenterol       Date:  1982-01       Impact factor: 2.423

2.  Frequent loss of a p53 allele in carcinomas and their precursors in ulcerative colitis.

Authors:  G C Burmer; D A Crispin; V R Kolli; R C Haggitt; B G Kulander; C E Rubin; P S Rabinovitch
Journal:  Cancer Commun       Date:  1991-06

3.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.

Authors:  J S Beckman; T W Beckman; J Chen; P A Marshall; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

4.  Microsatellite alteration at chromosome 3p loci in neuroendocrine and non-neuroendocrine lung tumors. Histogenetic and clinical relevance.

Authors:  K Hurr; B Kemp; S A Silver; A K el-Naggar
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

5.  Frequent microsatellite instability in post hepatitis B viral cirrhosis.

Authors:  M Salvucci; A Lemoine; D Azoulay; M Sebagh; H Bismuth; M Reyns; E May; B Debuire
Journal:  Oncogene       Date:  1996-12-19       Impact factor: 9.867

6.  The pattern of cell proliferation in neoplastic and nonneoplastic lesions of ulcerative colitis.

Authors:  A E Noffsinger; M A Miller; M V Cusi; C M Fenoglio-Preiser
Journal:  Cancer       Date:  1996-12-01       Impact factor: 6.860

7.  Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential.

Authors:  U Broomé; R Löfberg; B Veress; L S Eriksson
Journal:  Hepatology       Date:  1995-11       Impact factor: 17.425

8.  Rectal cell proliferation and colon cancer risk in ulcerative colitis.

Authors:  G Biasco; G M Paganelli; M Miglioli; S Brillanti; G Di Febo; G Gizzi; M Ponz de Leon; M Campieri; L Barbara
Journal:  Cancer Res       Date:  1990-02-15       Impact factor: 12.701

9.  Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer.

Authors:  H J Han; A Yanagisawa; Y Kato; J G Park; Y Nakamura
Journal:  Cancer Res       Date:  1993-11-01       Impact factor: 12.701

10.  Modification of DNA bases in chromatin of intact target human cells by activated human polymorphonuclear leukocytes.

Authors:  M Dizdaroglu; R Olinski; J H Doroshow; S A Akman
Journal:  Cancer Res       Date:  1993-03-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.